Schizophrenia study: Iloperidone
Official title Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
ClinicalTrials.gov ID: NCT05648591
What this study is testing
What is Iloperidone?
An investigational oral tablet being studied as a potential treatment for schizophrenia in adolescents. Iloperidone is designed to block dopamine and serotonin receptors in the brain.
Also referred to as VYV-683, FANAPT.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether iloperidone is safe and tolerable for teens with schizophrenia or bipolar I disorder.
- Who it's for
- You may be able to join if you are a teenager with schizophrenia or bipolar I disorder.
- What's involved
- You would take iloperidone, a medicine, each day. You will have regular check‑ins with the study team.
- Time commitment
- The study lasts up to 52 weeks with regular visits.
- Phase 4: studies an already-approved treatment
- Time commitment: about 52 weeks
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- Patient is willing and able to provide assent and willing to complete all aspects of the study
- Patient's parent or legal guardian willing and able to provide consent
- Male or female patients 12 through 17 years of age (inclusive)
- Clinical diagnosis of either schizophrenia or bipolar I disorder
You likely can't join if
- Use of other investigational drugs at the time of enrollment, or within 30 days or 5 half-lives of enrollment, whichever is longer
- A positive test for drugs of abuse
The study team makes the final eligibility decision.
Where it is enrolling
- Dothan, Alabama, United States
- Little Rock, Arkansas, United States
- Denver, Colorado, United States
- Atlanta, Georgia, United States
- Decatur, Georgia, United States
- Kinston, North Carolina, United States
- Cincinnati, Ohio, United States
- Garfield Heights, Ohio, United States
- Westlake, Ohio, United States
- Everett, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 52 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Dothan, Alabama, United States; Little Rock, Arkansas, United States; Denver, Colorado, United States; Atlanta, Georgia, United States; Decatur, Georgia, United States; Kinston, North Carolina, United States and 4 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.